berberine has been researched along with Complications of Diabetes Mellitus in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "To give an overview of the therapeutic potential of berberine as a treatment for dementia associated with diabetes." | 9.05 | Berberine for prevention of dementia associated with diabetes and its comorbidities: A systematic review. ( Bell, J; Bligh, A; Katsuno, T; Parkinson, J; Shinjyo, N, 2020) |
| "To give an overview of the therapeutic potential of berberine as a treatment for dementia associated with diabetes." | 5.05 | Berberine for prevention of dementia associated with diabetes and its comorbidities: A systematic review. ( Bell, J; Bligh, A; Katsuno, T; Parkinson, J; Shinjyo, N, 2020) |
| "Berberine (BBR) is a type of alkaloids isolated from Coptidis Rhizoma and Phellodendri Chinensis Cortex and has been used to treat bacterial gastroenteritis, diarrhea and other digestive diseases for more than 1 000 years." | 2.52 | [Effect of berberine in treating type 2 diabetes mellitus and complications and its relevant mechanisms]. ( Chen, L; Li, Y; Zhang, Q, 2015) |
| "Berberine is an isoquinoline alkaloid widely used in Asian countries as a traditional medicine." | 1.38 | Possible therapeutic potential of berberine in diabetic osteopathy. ( Bhutada, PS; Kaulaskar, SV; Rahigude, AB, 2012) |
| "Berberine treatments showed significant improvements as indicated by significantly increased NO release, NOS and thrombomodulin production." | 1.37 | Amelioration effects of berberine on diabetic microendothelial injury model by the combination of high glucose and advanced glycation end products in vitro. ( Du, JL; Hao, M; Li, CX; Li, H; Li, SY; Lin, Y; Liu, KX; Sun, CK; Wang, L; Zhou, Q, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Shinjyo, N | 1 |
| Parkinson, J | 1 |
| Bell, J | 1 |
| Katsuno, T | 1 |
| Bligh, A | 1 |
| Behl, T | 1 |
| Gupta, A | 1 |
| Sehgal, A | 1 |
| Sharma, S | 1 |
| Singh, S | 1 |
| Sharma, N | 1 |
| Diaconu, CC | 1 |
| Rahdar, A | 1 |
| Hafeez, A | 1 |
| Bhatia, S | 1 |
| Al-Harrasi, A | 1 |
| Bungau, S | 1 |
| Zhang, Q | 1 |
| Li, Y | 1 |
| Chen, L | 1 |
| Yang, HZ | 1 |
| Zhou, MM | 1 |
| Zhao, AH | 1 |
| Xing, SN | 1 |
| Fan, ZQ | 1 |
| Jia, W | 1 |
| Hao, M | 1 |
| Li, SY | 1 |
| Sun, CK | 1 |
| Lin, Y | 1 |
| Liu, KX | 1 |
| Wang, L | 1 |
| Li, CX | 1 |
| Zhou, Q | 1 |
| Du, JL | 1 |
| Li, H | 1 |
| Rahigude, AB | 1 |
| Kaulaskar, SV | 1 |
| Bhutada, PS | 1 |
3 reviews available for berberine and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
Berberine for prevention of dementia associated with diabetes and its comorbidities: A systematic review.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Berberine; Brain; Cholinergic Agonists; Cognitive Dysfunct | 2020 |
A spotlight on underlying the mechanism of AMPK in diabetes complications.
Topics: AMP-Activated Protein Kinases; Animals; Berberine; Diabetes Complications; Diabetes Mellitus, Type 2 | 2021 |
[Effect of berberine in treating type 2 diabetes mellitus and complications and its relevant mechanisms].
Topics: Animals; Berberine; Blood Glucose; Diabetes Complications; Diabetes Mellitus, Type 2; Drugs, Chinese | 2015 |
3 other studies available for berberine and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
[Study on effects of baicalin, berberine and Astragalus polysaccharides and their combinative effects on aldose reductase in vitro].
Topics: Aldehyde Reductase; Astragalus propinquus; Berberine; Diabetes Complications; Enzyme Inhibitors; Fla | 2009 |
Amelioration effects of berberine on diabetic microendothelial injury model by the combination of high glucose and advanced glycation end products in vitro.
Topics: Animals; Berberine; Cell Extracts; Cell Line; Diabetes Complications; Dose-Response Relationship, Dr | 2011 |
Possible therapeutic potential of berberine in diabetic osteopathy.
Topics: Berberine; Calcitonin; Diabetes Complications; Glucagon-Like Peptides; Glycation End Products, Advan | 2012 |